15 research outputs found
Compounds of the 16-Membered Macrocyclic Tetraamine (4RS,12RS)-2,2,4,10,10,12-Hexamethyl-1,5,9,13-tetraaza-cyclohexadecane with Cobalt(II), Nickel(II), Copper(II) and Zinc(II); Structural and Molecular Mechanics Studies
No full textSynthesis and Structure of (17-Hydroxy-4,4,9,9,11- pentamethyl-5,8,12,13,15-pentaazaheptadec- 11-en-2-one hydrazone)nickel(II) Perchlorate; a Compound with a Hexadentate gem-Diamine Ligand
No full textμ-Chloro-1:2κ3Cl-(2,4-dimethyl-5,8-diazadec-4-ene-2,10-diamine-1κ4N,N',N'',N''')copper(II)zinc(II)
No full textCopper(II) Compounds with Amine Imine Ligands; Structures of (2,4,6,9,11-Pentamethyl-5,8-diazadodeca-4,8-diene-2,11-diamine)copper(II) Perchlorate and (2,4-Dimethyl-5,8,11- triazatridec-4-ene-2,13-diamine)copper(II) Perchlorate
No full textA nickel(II) compound with a tetradentate diamine-diimine ligand, (2,4,6,9,11-pentamethyl-5,8-diazadodeca-4,8-diene-2,11-diamine)nickel(II) tetrachlorozincate
No full textSome Di- and tri-nuclear compounds of copper(II) with 4-amino-4-methylpentan-2-one oxime; structures and magnetism
No full textDi-μ-olato dinuclear copper(II) compounds. The structure of Bis-μ-O-[(4,6,6-trimethyl-9-(pyridin-2-yl)-3,7-diazanon-3-en-1-olato)copper(II)] perchlorate
No full textCopper(II) Compounds of 5-Alkyl-3,5,7-triazanonane-1,9-diamines and 3,10-Bisalkyl-1,3,5,8,10,12-hexaaza-cyclotetradecanes; the Structure of 1R,5S,8R,12S-{3,10-Bis(2-hydroxypropyl)-1,3,5,8,10,12-hexaaza-cyclotetradecane-N1,N5,N8,N12} copper(II) Perchlorate
No full textCompounds of Copper(II) and Nickel(II) with 6,8,8,13,13,15-Hexamethyl-1,2,4,5,9,12- hexaazacyclopentadeca-5,15(1)-diene and Some 3-Substituted Homologues
No full textFluorine and chlorine substituted adamantyl-urea as molecular tools for inhibition of human soluble epoxide hydrolase with picomolar efficacy
Get PDFAbstractSeries of 1,3-disubstituted ureas and diadamantyl disubstituted diureas with fluorinated and chlorinated adamantane residues were shown to inhibit human soluble epoxide hydrolase (sEH) with inhibition potency ranging from 40 pM to 9.2 nM. The measured IC50 values for some molecules were below the accuracy limit of the existing in vitro assays. Such an increase in activity was achieved by minimal structural modifications to the molecules of known inhibitors, including 4-[trans-4-(1-adamantylcarbamoylamino)cyclohexyl]oxybenzoic acid. For the chlorinated homologue of the latter the sharp jump in inhibitory activity can be (according to molecular dynamics data) the result of interactions – Cl-π interaction. Considering the extremely high inhibitory activity, acceptable solubility and partial blockage of metabolically sensitive centres in their structures, some compounds are of interest for further in vivo biotesting
